- Filed
- Mar 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Investments | FY 2025 · Jan 31, 2025 | $2.11B |
| Short Term Investments | FY 2025 · Jan 31, 2024 | $1.87B |
| Current Liabilities | FY 2025 · Jan 31, 2024 | $1.78B |
| Total Liabilities | FY 2025 · Jan 31, 2024 | $3.1B |
| Current Assets | FY 2025 · Jan 31, 2024 | $2.98B |
| Total Assets | FY 2025 · Jan 31, 2024 | $8.99B |
| Shares Diluted | FY 2025 · Jan 31, 2023 | 158.02M sh |
| Capex | FY 2025 · Jan 31, 2023 | $12M |
| Operating Cash Flow | FY 2025 · Jan 31, 2023 | $86M |
| Cash And Equivalents | FY 2025 · Jan 31, 2023 | $264M |
| Eps Diluted | FY 2025 · Jan 31, 2023 | −$5.16 |
| Eps Basic | FY 2025 · Jan 31, 2023 | −$5.16 |
| Sga Expense | FY 2025 · Jan 31, 2023 | $409M |
| Rd Expense | FY 2025 · Jan 31, 2023 | $620M |
| Net Income | FY 2025 · Jan 31, 2023 | −$815M |
| Operating Income | FY 2025 · Jan 31, 2023 | −$812M |
| Gross Profit | FY 2025 · Jan 31, 2023 | $1.31B |
| Cost Of Revenue | FY 2025 · Jan 31, 2023 | $546M |
| Revenue | FY 2025 · Jan 31, 2023 | $1.86B |
| Stockholders Equity restated | FY 2025 · Jan 31, 2022 | $5.92B |